- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 345.22M sh |
| Shares Outstanding | Q1 2025 · Mar 31, 2024 | 340.15M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $132.6M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $104.97M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $104.99M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $73.96M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $162.94M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $150.32M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $987.06M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $915.45M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.2B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.1B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $997.93M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $858.41M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.82B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.71B |
| Operating Income | Q1 2025 · Mar 31, 2025 | $25.73M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $12.22M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $104.78M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $131.21M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.54M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $58.24M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $118.5M |